Addison Advisors LLC

Position in ADMA — Adma Biologics, Inc.

CIK 1843745 MIDDLEBURY, VT

Position in ADMA

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$4,185

-$320 QoQ

Shares Held

500

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#288

of 321 holders

Holding Since

Sep 2022

16 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Addison Advisors LLC holds $20,811 across 8 Biotechnology names. ADMA ranks #3 (20.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GMAB	Genmab A/S	209	$5,741
2	ARGX	Argenx SE	5	$4,638
3	ADMA	Adma Biologics, Inc. This page	500	$4,185
4	VRTX	Vertex Pharmaceuticals Inc / Ma	7	$3,477
5	REGN	Regeneron Pharmaceuticals, Inc.	2	$1,247
6	INCY	Incyte Corp	6	$680
7	CGEN	Compugen Ltd	267	$571
8	CRSP	CRISPR Therapeutics AG	5	$272

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,185	500	0.0%	Shares	Sole	2026-08-10
2026-03-31	$4,505	500	0.0%	Shares	Sole	2026-05-08
2025-12-31	$9,120	500	0.0%	Shares	Sole	2026-02-06
2025-09-30	$7,330	500	0.0%	Shares	Sole	2025-11-07
2025-06-30	$9,105	500	0.0%	Shares	Sole	2025-08-07
2025-03-31	$9,920	500	0.0%	Shares	Sole	2025-05-12
2024-12-31	$8,575	500	0.0%	Shares	Sole	2025-02-04
2024-09-30	$9,995	500	0.0%	Shares	Sole	2024-11-04
2024-06-30	$5,590	500	0.0%	Shares	Sole	2024-08-05
2024-03-31	$3,300	500	0.0%	Shares	Sole	2024-05-06
2023-12-31	$2,260	500	0.0%	Shares	Sole	2024-02-02
2023-09-30	$1,790	500	0.0%	Shares	Sole	2023-11-07
2023-06-30	$1,845	500	0.0%	Shares	Sole	2023-08-03
2023-03-31	$1,655	500	0.0%	Shares	Sole	2023-05-09
2022-12-31	$1,940	500	0.0%	Shares	Sole	2023-02-07
2022-09-30	$1,215	500	—	Shares	Sole	2022-10-31
No filing history on record for this holder in this stock.